Please login to the form below
Intas Pharma
This page shows the latest Intas Pharma news and features for those working in and with pharma, biotech and healthcare.
Teva sells UK and Ireland assets to Intas Pharma for £603m
Under the terms of the deal, a chunk of Actavis' operations in the UK and Ireland will be sold to Accord Healthcare, a subsidiary of Indian generics firm Intas Pharmaceuticals, for ... Accord will claim ownership of a portfolio of generic drugs as well
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
Deal Watch - May 2017
A deal values in the first quarter of 2017 versus first quarter 2016. This analysis includes medtech as well as pharma and biotech. ... Intas (pharma). 106. Bain and others. Investment. Dicerna (biotech). 70. M&A without debt.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Account Director – UK Office
-
Excellent salary and benefits
-
Events Executive
-
DOE
-
Senior Medical Writer
-
Competitive salary plus benefits
- Client Services Director- Flexible Working
-
Negotiable
- Account Manager – Healthcare advertising
-
Salary TBC
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
Subscribe to our email news alerts
- Novartis eyes potential new indication for Cosentyx
- J&J's Tremfya filed for approval in US for psoriatic arthritis
- Envision Pharma Group relocates to support expansion
- Biogen loses another pipeline drug to toxicity concerns
- Half of European cancer drug trials ‘biased’, says BMJ
- AZ, Merck’s Lynparza scores market-expanding clinical success
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Report: Customer experience, shaping digital healthcare
- In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
- Encouraging signs in biomarker R&D
- The cancer immunotherapy firms ramping-up biomarker R&D...
- Programmatic methodology and why you should be using it
- What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...
Quick links
Infographics
